Workup for Pericardial and Pleural Effusions
First-Line Diagnostic Approach
All patients with suspected pericardial or pleural effusions require a standardized first-level workup consisting of: auscultation, ECG, transthoracic echocardiography, chest X-ray, and routine blood tests including inflammatory markers (CRP and/or ESR), complete blood count with differential, renal and liver function tests, thyroid function, and cardiac injury markers (troponins, CK). 1
This algorithmic approach is recommended by the 2015 ESC guidelines and provides the foundation for risk stratification and subsequent management decisions 1.
Essential First-Level Testing (Perform in ALL Cases)
- Physical examination: Auscultation for pericardial rub, decreased breath sounds
- ECG: Look for diffuse ST elevation, PR depression, electrical alternans
- Transthoracic echocardiography: Quantify effusion size (>20 mm diastolic echo-free space is "large"), assess for tamponade physiology
- Chest X-ray: Detects pleural effusions >75 mL (lateral view) or >175 mL (frontal view) 2
- Blood work:
- CBC with differential (leukocytosis suggests infection/inflammation)
- CRP/ESR (elevated in inflammatory conditions)
- Troponins and CK (myopericarditis if elevated)
- Renal function, liver tests, thyroid function
Risk Stratification: Identifying High-Risk Features
Immediately assess for high-risk criteria that mandate aggressive workup and intervention, as these predict identifiable and specifically treatable causes (bacterial, neoplastic, systemic inflammatory disease). 1
Major High-Risk Factors:
- Fever >38°C
- Subacute course (symptoms over days to weeks)
- Large pericardial effusion (>20 mm diastolic echo-free space)
- Cardiac tamponade
- Failure to respond to aspirin or NSAIDs
Common pitfall: In older adults (≥65 years), the presentation differs significantly—dyspnea is more common than chest pain (54% vs 33%), fever is less frequent, and leukocyte counts are lower, making diagnosis more challenging 3. Maintain high clinical suspicion despite atypical presentations.
Second-Level Testing (For High-Risk Patients or When First-Level Insufficient)
Advanced Imaging
CT chest with IV contrast is the reference standard for pleural effusions (detects >10 mL) and is recommended as second-level testing for pericardial disease workup. 1, 2 Cardiac MRI is an alternative second-line modality 1.
- CT chest with contrast: Provides detailed characterization of effusion, identifies loculations, distinguishes empyema from simple parapneumonic effusion 2
- Thoracic ultrasound: Most sensitive for small effusions (detects >20 mL), useful for procedure guidance 2
Invasive Sampling: When to Drain
Pericardiocentesis or surgical drainage are indicated for: (1) cardiac tamponade, (2) suspected bacterial pericarditis, (3) suspected neoplastic pericarditis, or (4) symptomatic moderate-to-large effusions not responding to medical therapy. 1
For pleural effusions, thoracentesis is indicated when the etiology is unclear or when parapneumonic effusion/empyema is suspected 2.
Fluid Analysis Protocol
Pericardial Fluid Analysis (when obtained):
Essential tests 1:
- Cytology: Cell count and differential (centrifugation improves yield)
- Microbiology: Aerobic/anaerobic cultures, mycobacterial cultures
- PCR: Specifically for tuberculosis
- Biochemistry: Protein, LDH (though not validated for pericardial fluid as they are for pleural fluid)
Pleural Fluid Analysis:
Distinguish transudative from exudative effusions 4:
Light's criteria (exudate if any present):
- Pleural fluid protein/serum protein >0.5
- Pleural fluid LDH/serum LDH >0.6
- Pleural fluid LDH >2/3 upper limit of normal serum LDH
Additional tests: pH (empyema if <7.2), glucose (low in infection/malignancy), cytology, cultures 4
Important distinction: Transudative effusions (heart failure, cirrhosis, renal failure) typically don't require extensive workup beyond treating the underlying condition. Exudative effusions (infection, malignancy, autoimmune) demand thorough investigation 2, 4.
Etiology-Specific Testing in High-Risk Patients
When high-risk features are present, pursue targeted testing based on clinical suspicion 1:
Suspected Autoimmune Disease:
- ANA, ENA, ANCA
- Ferritin (if Still's disease suspected)
- ACE and 24-hour urinary calcium (if sarcoidosis suspected)
- Consider PET scan for large vessel arteritis or sarcoidosis
Suspected Tuberculosis:
- IGRA test (QuantiFERON, ELISpot)
- Chest CT scan
- PCR on pericardial/pleural fluid
Suspected Malignancy:
- Chest and abdomen CT scan
- Consider PET scan
- Cytology from fluid analysis
Suspected Viral Infection:
- PCR for viral genome (preferred over serology)
- Serology for HCV and HIV
Suspected Bacterial Infection:
- Blood cultures before antibiotics
- Serology for Coxiella burnetii (Q fever) if suspected
Special Considerations for Concurrent Pleural and Pericardial Effusions
When both effusions are present simultaneously, consider an extensive differential including infectious, inflammatory, neoplastic, and iatrogenic causes. 5 The presence of both effusions suggests systemic disease rather than isolated pleural or pericardial pathology. In pericarditis with pleural effusion, the pleural effusions are typically bilateral, small, and exudative 6. Approximately 39% of pericarditis patients have concurrent pleural effusions 6.
Management Implications
The rate of fluid accumulation, not absolute size, determines hemodynamic significance and urgency of intervention. 7, 8 Rapidly accumulating effusions cause tamponade even with smaller volumes, while slowly accumulating effusions can reach large sizes before becoming symptomatic.
- Tamponade or impending tamponade: Urgent/emergent pericardiocentesis—do not delay for medical treatment 9
- Large symptomatic effusions without tamponade: Consider drainage for symptom control 6
- Small asymptomatic effusions with known etiology: Treat underlying cause with careful observation 9
- Treatment-refractory cases: May require indwelling pleural catheters or surgical intervention 6
Critical pitfall: In older adults, corticosteroids are used more frequently (50% vs 27%) and NSAIDs/colchicine less frequently due to comorbidities and drug interactions 3. Adjust treatment approach based on age and comorbidity burden.